Minnesota 2025-2026 Regular Session

Minnesota Senate Bill SF3960

Introduced
2/26/26  

Caption

Technical assistance and legal services requirement to the prescription drug affordability advisory council

Summary

SF 3960 would amend Minnesota Statutes section 62J.88 to require state support for the prescription drug affordability advisory council. Specifically, it directs the commissioner of commerce to provide technical assistance to the council and the attorney general to provide legal services to it. The bill does not create a new council or change the council’s substantive duties; instead, it adds state-agency support obligations to help the council carry out its work. The measure is narrowly focused on administrative support for the council’s prescription drug affordability activities. By placing these duties in statute, it formalizes the involvement of the Department of Commerce and the Attorney General’s Office in the council’s operations and may help ensure the council has access to policy, regulatory, and legal expertise when evaluating drug affordability issues.

Impact

The bill would amend Minnesota law governing the prescription drug affordability advisory council by adding a new subdivision to section 62J.88. It would require the commissioner of commerce to provide technical assistance and the attorney general to provide legal services, thereby creating an ongoing statutory obligation for two state offices to support the council. The practical effect is to strengthen the council’s administrative and legal capacity without directly changing prescription drug pricing rules, enforcement authority, or benefits coverage.

Sentiment

Based on the available record, the bill appears to be a routine, low-conflict administrative measure. There are no committee transcripts or recorded votes showing debate, opposition, or amendments, and the bill was introduced and referred to the Senate State and Local Government Committee. The absence of recorded controversy suggests the proposal was viewed as a technical support measure rather than a policy overhaul.

Contention

No specific points of contention are documented in the available materials. If concerns were to arise, they would likely center on the added workload for the commissioner of commerce and the attorney general, or on whether the state should statutorily commit legal and technical resources to the advisory council. However, no such objections are reflected in the bill history provided.

Companion Bills

No companion bills found.

Previously Filed As

MN SF5046

Prescription Drug Affordability Advisory Council elimination

MN SF5162

Drug Affordability Advisory Council elimination provision, various financial institutions and health plan provisions modifications, and appropriation

MN HF4881

Prescription Drug Affordability Advisory Council eliminated, nondepository financial institution provisions modified, health plan regulatory alignment provided, duties transferred, premium security plan modified, appropriations reduced, and money appropriated.

MN SB212

Enacting the prescription drug cost and affordability review act to establish the prescription drug pricing board and prescription drug affordability stakeholder council to review the cost of prescription medications and establish upper payment limits for certain prescription drugs.

MN SB357

Prescription Drug Affordability Board - Authority and Stakeholder Council Membership (Lowering Prescription Drug Costs for All Marylanders Now Act)

MN HB424

Prescription Drug Affordability Board - Authority and Stakeholder Council Membership (Lowering Prescription Drug Costs for All Marylanders Now Act)

MN SF4419

Various prescription drug transaction, coverage, and data provisions modifications

MN SF3859

Coverage without cost-sharing requirement of immunization for routine use without a prescription, Minnesota Science-Based Vaccine Advisory Council establishment, and appropriation

MN HB890

To enact sections 3901.85, 3901.851, 3901.852, 3901.853, 3901.854, 3901.855, 3901.856, 3901.857, and 3901.858 and to repeal section 125.95 of the Revised Code to establish the Prescription Drug Affordability Board and Prescription Drug Affordability Stakeholder Council, to authorize the establishment of upper payment limits on certain prescription drug products, to repeal the law establishing the Prescription Drug Transparency and Affordability Advisory Council, and to name this act the Prescription Relief and Inflation Cost Elimination or P.R.I.C.E. Act.

MN SF2477

Health insurance, Medicare supplement benefits and prescription drugs provisions modifications

Similar Bills

No similar bills found.